This is a list of all the questions and their associated study carrel identifiers. One can learn a lot of the "aboutness" of a text simply by reading the questions.
| identifier | question |
|---|---|
| 10_1101-2020_09_02_279521 | What Have We Learned from Expedition III and EPOCH Trials? |
| 10_1101-2020_11_17_386649 | Big data: astronomical or genomical? |
| 10_1101-2021_02_01_429246 | In particular, most research concentrates on the average case: what is the lowest expected density given a long random input sequence? |
| 10_1101-2021_02_08_430280 | ( 2013) TRNA modifications: Necessary for correct tRNA- derived fragments during the recovery from stress? |
| 10_1101-2021_02_09_430363 | How Does Your Cortex Grow? |
| 10_1101-2021_02_11_430806 | How do intrinsically disordered protein regions encode a driving force for liquid- liquid phase separation? |
| 10_1101-2021_02_11_430847 | Groves IJ, Coleman N. Human papillomavirus genome integration in squamous carcinogenesis: what have next- generation sequencing studies taught us? |
| 10_1101-2021_02_11_430871 | How significant is a protein structure similarity with TM- score= 0.5?. |
| 10_1101-2021_02_08_428881 | Ribeiro, M., Singh, S., and Guestrin, C."why should i trust you? |
| 10_1101-2021_02_12_430989 | Why weight? |
| 10_1101-2021_02_12_430979 | Is it time to change the reference genome? |
| 10_1101-2021_02_10_430623 | How many biological replicates are needed in an RNA- seq experiment and which differential expression tool should you use? |
| 10_1101-2021_02_10_430623 | RNA- seq differential expression studies: more sequence or more replication? |
| 10_1101-2021_02_12_430830 | Without such capability, the answer to the question “ Is it the mutation rate or the death rate? ” would always be “ mutation rate ”. |
| 10_1101-2021_02_12_430830 | [ 3] Tomlinson I, Sasieni P and Bodmer W. How Many Mutations in a Cancer? |
| 10_1101-2021_02_08_430343 | Model Accuracy GO results? |
| 10_1101-2021_02_08_430343 | Model Accuracy GO results? |
| 10_1101-698605 | So why did we embark on another comparative study? |
| 10_1101-698605 | Why is this happening? |
| 10_1101-2021_02_11_430762 | 7612/5 669/288 990/197 103016/29968 all 1-sequence tests? |
| 10_1101-2021_02_11_430762 | 7617/103 957/41 1187/396 132984/2268 expected span? |
| 10_1101-2021_02_11_430695 | But why do log- ratios form the basis of CoDa methodology? |
| 10_1101-2021_02_11_430695 | What can go wrong at the data normalization step for identification of biomarkers? |
| 10_1101-2021_02_11_430789 | Are Ab- stracts Enough for Hypothesis Generation?. |
| 10_1101-2021_02_11_430789 | Can Melatonin Be a Potential “ Silver Bullet ” in Treating COVID-19 Patients? |
| 10_1101-2021_02_11_430789 | Is there an underlying link between COVID-19, ACE2, oxytocin and vitamin D? |
| 10_1101-2021_02_11_430789 | Why is COVID-19 less severe in children? |
| 10_1101-2020_01_28_923532 | Arnedos, M., Vielh, P., Soria, J.C.& Andre, F. The genetic complexity of common cancers and the promise of personalized medicine: is there any hope? |
| 10_1101-2020_01_28_923532 | First, how many targeted treatments are needed to selectively kill most tumor cells while sparing most of the non- tumor cells in a given patient? |
| 10_1101-2021_02_10_430563 | Are some subjects missing data? |
| 10_1101-2021_02_10_430563 | E.g., first open file X and then look at file Y. o What additional details do they need to know? |
| 10_1101-2021_02_10_430563 | Some information that should be included are: o How would a user use the files that are provided? |
| 10_1101-2021_02_10_430563 | e.g., did you provide a GitHub repository or are there additional papers beyond what was provided in the metadata form? |
| 10_1101-2021_02_10_430563 | o Are there appropriate/ inappropriate uses for this data? |
| 10_1101-2021_02_10_430563 | o Are there other places that users can go for more information? |
| 10_1101-2021_02_10_430563 | o Are there warnings about how to use the data or code? |
| 10_1101-2021_02_10_430563 | sub??-task1-run?? |
| 10_1101-2021_02_10_430563 | sub??-task1-run?? |
| 10_1101-2020_10_08_327718 | Are any annotations, arrows or labels clearly explained for all images in the paper? |
| 10_1101-2020_10_08_327718 | Are colors in images explained either on the image or within the legend? |
| 10_1101-2020_10_08_327718 | Did a change in Nature journals ’ editorial policy for life sciences research improve reporting? |
| 10_1101-2020_10_08_327718 | Did the paper contain appropriately labeled scale bars for all images? |
| 10_1101-2020_10_08_327718 | If the paper contains colored labels, are these labels visible to someone with the most common form of color blindness( deuteranopia)? |
| 10_1101-2020_10_08_327718 | Is the species and tissue, object, or cell line name clearly specified in the figure or legend for all images in the paper? |
| 10_1101-2020_10_08_327718 | Were all insets clearly and accurately marked? |
| 10_1101-2020_10_08_327718 | Were all insets clearly explained in the legend? |
| 10_1101-2020_10_08_327718 | fluorescence microscopy), are key features of the images visible to someone with the most common form of colorblindness( deuteranopia)? |